Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
This week, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) announced the “Berlin Declaration,” a framework to collaborate with the G7 and G20 […]
According to a study published earlier this year in The Lancet, antimicrobial-resistant infections have become a leading global cause of mortality. The study showed
AMR could be worse than the COVID-19 pandemic, experts say Read More »
The House of Representatives passed legislation on Wednesday, July 20, that would give the U.S. Food and Drug Administration (FDA) the direction and resources
House passes Ag-FDA spending bill that boosts biotech Read More »
The most recent data from the Bureau of Labor Statistics (BLS), which came out last week, shows that drug prices are rising more slowly
BLS: Inflation is way up – but drug prices are not Read More »
More than two years on from COVID, offices and the world of work remain forever changed. Many companies are offering hybrid work models, where
How biotech recruiting has changed in the post-COVID world Read More »
“It seems implausible that a nation as technologically advanced as the United States could still struggle to feed itself. But it does,” writes Biotechnology
Biotech is a solution to U.S. nutrition problems, says BIO President and CEO Read More »
Ahead of today’s House Select Committee on the Climate Crisis hearing on food supply chains, BIO submitted comments highlighting the need to incentivize the
Climate change will exacerbate food crisis, says BIO Read More »
According to recent polling data performed by Morning Consult on behalf of the Biotechnology Innovation Organization (BIO), registered voters in five states strongly favor
Voters overwhelmingly support Accelerated Approval, says BIO/Morning Consult poll Read More »
It feels like just yesterday that Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), visited member company Novavax with Maryland
Misinformation. Not COVID. Not heart disease. Not cancer. Misinformation. That’s what the Commissioner of the U.S. Food and Drug Administration recently declared the leading
BIO Board Member: Biotech’s voice needs to get louder – and clearer Read More »
